Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Foley, R. N.
Right arrow Articles by Barre, P. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Foley, R. N.
Right arrow Articles by Barre, P. E.

Journal of the American Society of Nephrology, Vol 5, 2024-2031, Copyright © 1995 by American Society of Nephrology

REGULAR ARTICLES

The prognostic importance of left ventricular geometry in uremic cardiomyopathy

RN Foley, PS Parfrey, JD Harnett, GM Kent, DC Murray and PE Barre
Division of Nephrology, Memorial University, St John's, Newfoundland, Canada.

The objective of this study was to determine the effect of left ventricular (LV) mass, volume, and mass-to-volume ratio on mortality in chronic dialysis patients. The Design was a multicenter, prospective inception cohort study with a median follow-up of 41 months. The Setting was three university-affiliated nephrology units. A total of 433 patients who (1) survived > 6 months from the start of ESRD therapy and (2) had a technically satisfactory baseline echocardiogram were studied. Measurements included a baseline clinical, laboratory and echocardiographic assessment. LV hypertrophy was present in 74% and LV dilation was present in 36% of patients. In patients with normal cavity volume (< or = 90 mL/m2) and normal systolic function, high LV mass index (> 120 g/m2) and mass-to-volume ratios (> 2.2 g/mL) were independently associated with late mortality (> 2 yr after starting dialysis therapy). After adjusting for baseline age, diabetes, and ischemic heart disease, the relative risk for the former was 3.29 and for the latter was 2.24. Cavity volume was of no prognostic significance in this group. In patients with LV dilation and normal systolic function, high cavity volume (> 120 mL/m2) and low mass-to- volume ratio (< 1.8 mL/m2) were independently associated with late mortality, the relative risk in the former being 17.14 and the latter being 4.27. LV mass index was of no prognostic significance in this group. The baseline echocardiographic classification, based on LV mass and cavity volume, was the strongest predictor of late mortality, after adjusting for age, gender, diabetes mellitus, coronary artery disease, angina pectoris, chronic hypertension, and hemoglobin and serum albumin levels.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
S. Y. Hayashi, A. Seeberger, B. Lind, J. Nowak, M. M. do Nascimento, B. Lindholm, and L.-A. Brodin
A single session of haemodialysis improves left ventricular synchronicity in patients with end-stage renal disease: a pilot tissue synchronization imaging study
Nephrol. Dial. Transplant., November 1, 2008; 23(11): 3622 - 3628.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
C. P. Lee, S. A. Zenios, and G. M. Chertow
Cost-Effectiveness of Frequent In-Center Hemodialysis
J. Am. Soc. Nephrol., September 1, 2008; 19(9): 1792 - 1797.
[Abstract] [Full Text] [PDF]

Home page
 NDT PlusHome page
M. M. Sood, R. P. Pauly, C. Rigatto, and P. Komenda
Left ventricular dysfunction in the haemodialysis population
NDT Plus, August 1, 2008; 1(4): 199 - 205.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
N C Edwards, C J Ferro, J N Townend, and R P Steeds
Aortic distensibility and arterial-ventricular coupling in early chronic kidney disease: a pattern resembling heart failure with preserved ejection fraction
Heart, August 1, 2008; 94(8): 1038 - 1043.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
A. Y-M. Wang, M. Wang, C. W-K. Lam, I. H-S. Chan, Y. Zhang, and J. E. Sanderson
Left Ventricular Filling Pressure by Doppler Echocardiography in Patients With End-Stage Renal Disease
Hypertension, July 1, 2008; 52(1): 107 - 114.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
B. J. Foster, A. S. Mackie, M. Mitsnefes, H. Ali, S. Mamber, and S. D. Colan
A Novel Method of Expressing Left Ventricular Mass Relative to Body Size in Children
Circulation, May 27, 2008; 117(21): 2769 - 2775.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
M. Kessler, F. Zannad, P. Lehert, J. P. Grunfeld, C. Thuilliez, A. Leizorovicz, P. Lechat, and for the FOSIDIAL Investigators
Predictors of cardiovascular events in patients with end-stage renal disease: an analysis from the Fosinopril in Dialysis study
Nephrol. Dial. Transplant., December 1, 2007; 22(12): 3573 - 3579.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
D. Banerjee, J. Z. Ma, A. J. Collins, and C. A. Herzog
Long-Term Survival of Incident Hemodialysis Patients Who Are Hospitalized for Congestive Heart Failure, Pulmonary Edema, or Fluid Overload
Clin. J. Am. Soc. Nephrol., November 1, 2007; 2(6): 1186 - 1190.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
P. B. Mark, R. K. Patel, and A. G. Jardine
Are we overestimating left ventricular abnormalities in end-stage renal disease?
Nephrol. Dial. Transplant., July 1, 2007; 22(7): 1815 - 1819.
[Full Text] [PDF]

Home page
 CJASNHome page
J. Nogueira and M. Weir
The Unique Character of Cardiovascular Disease in Chronic Kidney Disease and Its Implications for Treatment with Lipid-Lowering Drugs
Clin. J. Am. Soc. Nephrol., July 1, 2007; 2(4): 766 - 785.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
M. Salvetti, M. L. Muiesan, A. Paini, C. Monteduro, B. Bonzi, G. Galbassini, E. Belotti, E. Movilli, G. Cancarini, and E. Agabiti-Rosei
Myocardial Ultrasound Tissue Characterization in Patients with Chronic Renal Failure
J. Am. Soc. Nephrol., June 1, 2007; 18(6): 1953 - 1958.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
R. Sharma, E. Chemla, M. Tome, R. L Mehta, H. Gregson, S. J D Brecker, R. Chang, and D. Pellerin
Echocardiography-based score to predict outcome after renal transplantation
Heart, April 1, 2007; 93(4): 464 - 469.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
G. Tripepi, F. A. Benedetto, F. Mallamaci, R. Tripepi, L. Malatino, and C. Zoccali
Left Atrial Volume Monitoring and Cardiovascular Risk in Patients with End-Stage Renal Disease: A Prospective Cohort Study
J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1316 - 1322.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
H. P. Patel, S. L. Goldstein, J. D. Mahan, B. Smith, C. B. Fried, H. Currier, and J. T. Flynn
A Standard, Noninvasive Monitoring of Hematocrit Algorithm Improves Blood Pressure Control in Pediatric Hemodialysis Patients
Clin. J. Am. Soc. Nephrol., March 1, 2007; 2(2): 252 - 257.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
S. G. Achinger and J. C. Ayus
Left Ventricular Hypertrophy: Is Hyperphosphatemia among Dialysis Patients a Risk Factor?
J. Am. Soc. Nephrol., December 1, 2006; 17(12_suppl_3): S255 - S261.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
S. Briese, S. Wiesner, J. C. Will, A. Lembcke, B. Opgen-Rhein, R. Nissel, K.-D. Wernecke, J. Andreae, D. Haffner, and U. Querfeld
Arterial and cardiac disease in young adults with childhood-onset end-stage renal disease--impact of calcium and vitamin D therapy
Nephrol. Dial. Transplant., July 1, 2006; 21(7): 1906 - 1914.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
P. B. Mark, G. A. Stewart, R. T. Gansevoort, C. J. Petrie, T. A. McDonagh, H. J. Dargie, R. S. C. Rodger, and A. G. Jardine
Diagnostic potential of circulating natriuretic peptides in chronic kidney disease
Nephrol. Dial. Transplant., February 1, 2006; 21(2): 402 - 410.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
S. Y. Hayashi, M. Rohani, B. Lindholm, L.-A. Brodin, B. Lind, P. Barany, A. Alvestrand, and A. Seeberger
Left ventricular function in patients with chronic kidney disease evaluated by colour tissue Doppler velocity imaging
Nephrol. Dial. Transplant., January 1, 2006; 21(1): 125 - 132.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
J. C. Ayus, M. R. Mizani, S. G. Achinger, R. Thadhani, A. S. Go, and S. Lee
Effects of Short Daily versus Conventional Hemodialysis on Left Ventricular Hypertrophy and Inflammatory Markers: A Prospective, Controlled Study
J. Am. Soc. Nephrol., September 1, 2005; 16(9): 2778 - 2788.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
D. Hernandez
Left ventricular hypertrophy after renal transplantation: new approach to a deadly disorder
Nephrol. Dial. Transplant., July 1, 2004; 19(7): 1682 - 1686.
[Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
C. Zoccali, F. A. Benedetto, F. Mallamaci, G. Tripepi, G. Giacone, A. Cataliotti, G. Seminara, B. Stancanelli, and L. S. Malatino
Prognostic Value of Echocardiographic Indicators of Left Ventricular Systolic Function in Asymptomatic Dialysis Patients
J. Am. Soc. Nephrol., April 1, 2004; 15(4): 1029 - 1037.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
M. J. Sarnak, A. S. Levey, A. C. Schoolwerth, J. Coresh, B. Culleton, L. L. Hamm, P. A. McCullough, B. L. Kasiske, E. Kelepouris, M. J. Klag, et al.
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease: A Statement From the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention
Hypertension, November 1, 2003; 42(5): 1050 - 1065.
[Full Text] [PDF]

Home page
 HypertensionHome page
C. T. Chan, P. J. Harvey, P. Picton, A. Pierratos, J. A. Miller, and J. S. Floras
Short-Term Blood Pressure, Noradrenergic, and Vascular Effects of Nocturnal Home Hemodialysis
Hypertension, November 1, 2003; 42(5): 925 - 931.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
M. J. Sarnak, A. S. Levey, A. C. Schoolwerth, J. Coresh, B. Culleton, L. L. Hamm, P. A. McCullough, B. L. Kasiske, E. Kelepouris, M. J. Klag, et al.
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease: A Statement From the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention
Circulation, October 28, 2003; 108(17): 2154 - 2169.
[Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
A. Toprak, M. Koc, H. Tezcan, I. C. Ozener, E. Akoglu, and A. Oktay
Inferior vena cava diameter determines left ventricular geometry in continuous ambulatory peritoneal dialysis patients: an echocardiographic study
Nephrol. Dial. Transplant., October 1, 2003; 18(10): 2128 - 2133.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
G. de Simone
Left Ventricular Geometry and Hypotension in End-Stage Renal Disease: A Mechanical Perspective
J. Am. Soc. Nephrol., October 1, 2003; 14(10): 2421 - 2427.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
K. J Smith, A. J Bleyer, W. C Little, and D. C Sane
The cardiovascular effects of erythropoietin
Cardiovasc Res, September 1, 2003; 59(3): 538 - 548.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
C. G. Rabbat, D. J. Treleaven, J. D. Russell, D. Ludwin, and D. J. Cook
Prognostic Value of Myocardial Perfusion Studies in Patients with End-Stage Renal Disease Assessed for Kidney or Kidney-Pancreas Transplantation: A Meta-Analysis
J. Am. Soc. Nephrol., February 1, 2003; 14(2): 431 - 439.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
D. Kennedy, E. Omran, S. M. Periyasamy, J. Nadoor, A. Priyadarshi, J. C. Willey, D. Malhotra, Z. Xie, and J. I. Shapiro
Effect of Chronic Renal Failure on Cardiac Contractile Function, Calcium Cycling, and Gene Expression of Proteins Important for Calcium Homeostasis in the Rat
J. Am. Soc. Nephrol., January 1, 2003; 14(1): 90 - 97.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
L. S. Malatino, A. Cataliotti, F. A. Benedetto, B. Stancanelli, I. Bellanuova, P. Belluardo, L. Bonaiuto, G. Tripepi, F. Mallamaci, P. Castellino, et al.
Hepatocyte Growth Factor and Left Ventricular Geometry in End-Stage Renal Disease
Hypertension, January 1, 2003; 41(1): 88 - 92.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
A. Covic, M. Diaconita, P. Gusbeth-Tatomir, M. Covic, A. Botezan, G. Ungureanu, and D. J. Goldsmith
Haemodialysis increases QTc interval but not QTc dispersion in ESRD patients without manifest cardiac disease
Nephrol. Dial. Transplant., December 1, 2002; 17(12): 2170 - 2177.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
K. Binley, Z. Askham, S. Iqball, H. Spearman, L. Martin, M. de Alwis, A. J. Thrasher, R. R. Ali, P. H. Maxwell, S. Kingsman, et al.
Long-term reversal of chronic anemia using a hypoxia-regulated erythropoietin gene therapy
Blood, September 18, 2002; 100(7): 2406 - 2413.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
C. Zoccali, F. Mallamaci, G. Tripepi, S. Parlongo, S. Cutrupi, F. A. Benedetto, A. Cataliotti, and L. S. Malatino
Norepinephrine and Concentric Hypertrophy in Patients With End-Stage Renal Disease
Hypertension, July 1, 2002; 40(1): 41 - 46.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
D. Goldsmith, R. MacGinley, A. Smith, and A. Covic
How important and how treatable is vascular stiffness as a cardiovascular risk factor in renal failure?
Nephrol. Dial. Transplant., June 1, 2002; 17(6): 965 - 969.
[Full Text] [PDF]

Home page
 CirculationHome page
C. Zoccali, F. Mallamaci, S. Parlongo, S. Cutrupi, F. A. Benedetto, G. Tripepi, G. Bonanno, F. Rapisarda, P. Fatuzzo, G. Seminara, et al.
Plasma Norepinephrine Predicts Survival and Incident Cardiovascular Events in Patients With End-Stage Renal Disease
Circulation, March 19, 2002; 105(11): 1354 - 1359.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
J. A. Coladonato, L. A. Szczech, E. A. Friedman, and W. F. Owen Jr
Does calcium kill ESRD patients--the skeptic's perspective
Nephrol. Dial. Transplant., February 1, 2002; 17(2): 229 - 232.
[Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
C. Zoccali, F. A. Benedetto, F. Mallamaci, G. Tripepi, G. Giacone, A. Cataliotti, G. Seminara, B. Stancanelli, and L. S. Malatino
Prognostic Impact of the Indexation of Left Ventricular Mass in Patients Undergoing Dialysis
J. Am. Soc. Nephrol., December 1, 2001; 12(12): 2768 - 2774.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
F. A. BENEDETTO, F. MALLAMACI, G. TRIPEPI, and C. ZOCCALI
Prognostic Value of Ultrasonographic Measurement of Carotid Intima Media Thickness in Dialysis Patients
J. Am. Soc. Nephrol., November 1, 2001; 12(11): 2458 - 2464.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
C. ZOCCALI, F. MALLAMACI, F. A. BENEDETTO, G. TRIPEPI, S. PARLONGO, A. CATALIOTTI, S. CUTRUPI, G. GIACONE, I. BELLANUOVA, E. COTTINI, et al.
Cardiac Natriuretic Peptides Are Related to Left Ventricular Mass and Function and Predict Mortality in Dialysis Patients
J. Am. Soc. Nephrol., July 1, 2001; 12(7): 1508 - 1515.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
E. O'Riordan and R. N. Foley
When should we start erythropoietin therapy?
Nephrol. Dial. Transplant., May 1, 2001; 16(5): 891 - 892.
[Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
J. Stoves, H. Inglis, and C. G. Newstead
A randomized study of oral vs intravenous iron supplementation in patients with progressive renal insufficiency treated with erythropoietin
Nephrol. Dial. Transplant., May 1, 2001; 16(5): 967 - 974.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
R. J. MIDDLETON, P. S. PARFREY, and R. N. FOLEY
Left Ventricular Hypertrophy in the Renal Patient
J. Am. Soc. Nephrol., May 1, 2001; 12(5): 1079 - 1084.
[Full Text]

Home page
 Nephrol Dial TransplantHome page
C. Zoccali, F. Mallamaci, G. Tripepi, and F. A. Benedetto
Autonomic neuropathy is linked to nocturnal hypoxaemia and to concentric hypertrophy and remodelling in dialysis patients
Nephrol. Dial. Transplant., January 1, 2001; 16(1): 70 - 77.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
R. E. Schmieder, J. Erdmann, C. Delles, J. Jacobi, E. Fleck, K. Hilgers, and V. Regitz-Zagrosek
Effect of the angiotensin II type 2-receptor gene (+1675 G/A) on left ventricular structure in humans
J. Am. Coll. Cardiol., January 1, 2001; 37(1): 175 - 182.
[Abstract] [Full Text] [PDF]

Home page
 ANGIOLOGYHome page
Y. Matsumoto, M. Hamada, and K. Hiwada
Aortic Distensibility is Closely Related to the Progression of Left Ventricular Hypertrophy in Patients Receiving Hemodialysis
Angiology, November 1, 2000; 51(11): 933 - 941.
[Abstract] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
R. N. FOLEY, P. S. PARFREY, G. M. KENT, J. D. HARNETT, D. C. MURRAY, and P. E. BARRE
Serial Change in Echocardiographic Parameters and Cardiac Failure in End-Stage Renal Disease
J. Am. Soc. Nephrol., May 1, 2000; 11(5): 912 - 916.
[Abstract] [Full Text]

Home page
 Nephrol Dial TransplantHome page
A. U. Klingbeil and R. E. Schmieder
Not all left ventricular hypertrophy is created equal
Nephrol. Dial. Transplant., December 1, 1999; 14(12): 2803 - 2805.
[Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
P. S. PARFREY and R. N. FOLEY
The Clinical Epidemiology of Cardiac Disease in Chronic Renal Failure
J. Am. Soc. Nephrol., July 1, 1999; 10(7): 1606 - 1615.
[Full Text]

Home page
 J. Am. Soc. Nephrol.Home page
P. ARORA, G. T. OBRADOR, R. RUTHAZER, A. T. KAUSZ, K. B. MEYER, C. S. JENULESON, and B. J. G. PEREIRA
Prevalence, Predictors, and Consequences of Late Nephrology Referral at a Tertiary Care Center
J. Am. Soc. Nephrol., June 1, 1999; 10(6): 1281 - 1286.
[Abstract] [Full Text]

Home page
 QJMHome page
A. Covic, D.J.A. Goldsmith, M.C. Venning, and P. Ackrill
Long-hours home haemodialysis—the best renal replacement therapy method?
QJM, May 1, 1999; 92(5): 251 - 260.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
B. Suwelack, J. Witta, M. Hausberg, S. Muller, K. Rahn, and M. Barenbrock
Studies on structural changes of the carotid arteries and the heart in asymptomatic renal transplant recipients
Nephrol. Dial. Transplant., January 1, 1999; 14(1): 160 - 165.
[Abstract] [PDF]

Home page
 BMJHome page
R. Walker
Recent advances :General management of end stage renal disease
BMJ, November 29, 1997; 315(7120): 1429 - 1432.
[Full Text]


HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673